Is this has anything to do with COVID-19? It seems they are not going to manufacture any anti-malaria medications, but more likely they are doing research on the drug-delivery system of anti-malaria medications?
How is this JV with a Swiss company with regards to a delivery system called MyCell is going to help with the company in long run? Is MXC going to become an anti-malaria drug company?
Now I understand why ASX need more disclosure...
Ann: Voluntary Suspension Extension, page-29
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.05M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1794 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 2500 | 1 |
View Market Depth
| Last trade - 07.00am 17/10/2024 (20 minute delay) ? |
| RGT (ASX) Chart |
Day chart unavailable